Dexrazoxane Intravenous and Insulin Glulisine (Vials)
Determining the interaction of Dexrazoxane Intravenous and Insulin Glulisine (Vials) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Insulin glulisine Subcutaneous
- Dexrazoxane Intravenous-Insulin human inhaled Inhalation
- Dexrazoxane Intravenous-Insulin human regular Injection
- Dexrazoxane Intravenous-Insulin inhalation
- Dexrazoxane Intravenous-Insulin isophane
- Dexrazoxane Intravenous-Insulin isophane and insulin regular
- Insulin Glulisine (Vials)-Dextenza Insert
- Insulin Glulisine (Vials)-Dextenza intraocular
- Insulin Glulisine (Vials)-Dextran 40
- Insulin Glulisine (Vials)-Dextran 70 6% in 5% Dextrose high molecular weight
- Insulin Glulisine (Vials)-Dextran 75
- Insulin Glulisine (Vials)-Dextran high molecular weight